Michael Constantino
Direttore/Membro del Consiglio presso HUMACYTE, INC.
Patrimonio netto: 36 075 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Michael Constantino
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 20 | |
Public Company | Biotechnology | 15 | |
North Carolina State University Foundation, Inc.
7
| Foundation/Endowment | 7 | |
Southeastern Biologics
Southeastern Biologics Medical/Nursing ServicesHealth Services Part of Merck KGaA, Southeastern Biologics is a company that operates donor centers. The company is based in Austin, TX. Southeastern Biologics was acquired by Serologicals Corp. on March 11, 1996 for $2.50 million.
1
| Subsidiary | Medical/Nursing Services | 1 |
NC State Investment Fund, Inc.
1
| Non-Profit Organization | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael Constantino tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Public Communications Contact | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Founder Director/Board Member Sales & Marketing | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member President | |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Medical Specialties | Director of Finance/CFO General Counsel Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Masters Business Admin | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Masters Business Admin | |
Morgan Stanley Investment Management Pvt Ltd.
Morgan Stanley Investment Management Pvt Ltd. Investment Banks/BrokersFinance Morgan Stanley Investment Management Pvt Ltd. (India) (MSIM), founded in 1993, is an asset management subsidiary of Morgan Stanley (NYSE: MS). The firm specializes in managing assets for a range of institutional clients, including endowments, foundations, pension funds, corporations, governments, and high-net worth individuals. The Mumbai office focuses on managing portfolios of Indian securities. MSIM has offices in New York, Philadelphia, Houston, Chicago, London, Tokyo, Amsterdam and Singapore. | Investment Banks/Brokers | Corporate Officer/Principal | |
ICICI Venture Funds Management Co. Ltd.
ICICI Venture Funds Management Co. Ltd. Investment ManagersFinance ICICI Venture Funds Management Co. Ltd (ICICI) is a Private Equity firm, a subsidiary of ICICI Bank Ltd. founded in 1988. The firm is headquartered in India. | Investment Managers | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Director/Board Member Corporate Officer/Principal | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree Undergraduate Degree | |
Georgia Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Chicago | College/University | Director/Board Member Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Malladi Drugs & Pharmaceuticals Ltd.
Malladi Drugs & Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Malladi Drugs & Pharmaceuticals Ltd. manufactures active pharmaceutical ingredients. It manufactures Ephedrine and Pseudo-Ephedrine. The firm's products include active pharmaceutical ingredients, intermediates and speciality products,and chiral building blocks and speciality chemicals. Its services include contract manufacturing, custom synthesis and contract research. The company was founded by M. L. N. Satry in 1980 and is headquartered in Chennai, India. | Pharmaceuticals: Major | Director/Board Member | |
Indian Institute of Technology Madras
Indian Institute of Technology Madras Other Consumer ServicesConsumer Services The Indian Institute of Technology, Madras, is among the foremost of institutes of national importance in higher technological education and in basic and applied research. The Institute, with nearly 360 faculty, 4000 students, 1250 administrative and supporting staff, is a self-contained campus and is located in a beautiful, wooded land of about 250 hectares in South Madras | College/University | Undergraduate Degree | |
Fudan University | College/University | Undergraduate Degree | |
Banaras Hindu University | College/University | Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
RELE NAVAPAR | Trucks/Construction/Farm Machinery | Chief Executive Officer | |
Avantor Performance Materials India Ltd.
Avantor Performance Materials India Ltd. Pharmaceuticals: MajorHealth Technology Avantor Performance Materials India Ltd. manufactures and distributes pharmaceutical products. Its products include acids, amino acids, aqueous solutions, biological regents and denaturants. The company was founded by John Townsend Baker in 1904 and is headquartered in Gurgaon, India. | Pharmaceuticals: Major | Director/Board Member | |
Arch Pharmalabs Ltd.
Arch Pharmalabs Ltd. Pharmaceuticals: MajorHealth Technology Arch Pharmalabs Ltd. manufactures and sells pharmaceutical products. Its therapeutic segments include side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs and Anti-Anginal segments. The company was founded in 1975 and is headquartered in Mumbai, India. | Pharmaceuticals: Major | Director/Board Member | |
Unimark Remedies Ltd.
Unimark Remedies Ltd. Pharmaceuticals: MajorHealth Technology Unimark Remedies Ltd. develops and markets active generic medicines. It specializes in pharmaceutical products for respiratory, cardiovascular, anti-infectives, and central nervous system. The company was founded in 1982 and is headquartered in Mumbai, India. | Pharmaceuticals: Major | Director/Board Member | |
Avendus Capital Pvt Ltd.
Avendus Capital Pvt Ltd. Investment Banks/BrokersFinance Avendus Capital Pvt Ltd. provides financial services. The firm offers financial advisory, mergers and acquisitions, private equity syndication, equity capital markets, structured finance, financial sponsors group, wealth management, alternative asset management, and institutional equities. The company was founded by Ranu Vohra, Gaurav Deepak and Kaushal Aggarwal and is headquartered in Mumbai, India. | Investment Banks/Brokers | Corporate Officer/Principal | |
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Medical/Nursing Services | Chief Executive Officer Founder | |
Bharat Biotech International Ltd.
Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Biotechnology | Director/Board Member | |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Chairman Director/Board Member Founder Director/Board Member Chief Executive Officer | |
I-VEN Medi-care India Pvt Ltd.
I-VEN Medi-care India Pvt Ltd. MiscellaneousMiscellaneous I-VEN Medicare India Pvt Ltd. provides investment services in the healthcare sectors. It invests in hospitals and research institutes. The company is headquartered in Bangalore, India. | Miscellaneous | Corporate Officer/Principal | |
Abt Bio-pharma Solutions, Inc.
Abt Bio-pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology The Abt Bio-Pharma Solutions team has provided integrated strategic, research, and communications services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for 25 years. Its parent company, Abt Associates Inc., is one of the largest research and consulting firms in the world, applying scientific expertise to a wide range of health, economic, social, environmental, and technological policy issues. Founded in 1965, Abt Associates has annual revenue in excess of $200 million and a staff of more than 1,000, including national and international experts who are recognized for their knowledge, innovative research techniques, and insightful analysis & recommendations. In the early 1980s, Abt Associates' staff of bio statisticians, clinicians, health economists, and strategic consultants began designing, analyzing, and reporting on clinical trials for a broad variety of drugs and devices covering many therapeutic areas. Over the next decade, their services for commercial sponsors grew to include registries and other real world studies designed to evaluate safety, efficacy, economic, patient compliance, and health-related quality-of-life factors. The Abt Associates Clinical Trials (AACT) division was created in 1997, combining capabilities in bio-statistics, data management, epidemiology, and clinical trials management. To help sponsors demonstrate product value in a competitive global marketplace, their Health Economic Research and Quality of Life Evaluation Services (HERQuLES) team was established and became a leader in collecting & analyzing data on the use of healthcare products & services and on their clinical, economic, quality of life, and satisfaction outcomes. In recent years, AACT expanded capabilities to include pricing & reimbursement & marketing consulting and research services, employing a cross-functional matrixed approach ideally suited for their clients' multifaceted needs. In April 2008, AACT was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates. Their new name reflects the full range of custom services they provide to sponsors globally. The ABS team continues Abt Associates' 40-year history of commitment to providing knowledge, delivering insight, and improving world health. | Pharmaceuticals: Major | Founder | |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Swiss Bio Pharma Pvt Ltd. | Director/Board Member | ||
LabCentral, Inc.
LabCentral, Inc. Miscellaneous Commercial ServicesCommercial Services LabCentral, Inc. provides grant making services for bio-tech companies. The firm?s services include maintenance of permits for all lab operations, mandatory EHS training and compliance for all lab users, maintenance of equipment and technical support, CRO support available on-site (FTE basis), cleaning and waste removal. The company was founded by Timothy D. Rowe, Johannes Fruehauf, Peter D. Parker in September 2012 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | President Sales & Marketing | |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Venturcap Financial Group LLC | Chief Executive Officer | ||
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | Miscellaneous Commercial Services | Director/Board Member | |
Bioscience Los Angeles County, Inc. | Chairman | ||
CARMELL CORPORATION | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 33 |
India | 14 |
Regno Unito | 3 |
Cina | 2 |
Israele | 2 |
Settori
Health Technology | 20 |
Consumer Services | 13 |
Finance | 9 |
Commercial Services | 4 |
Health Services | 3 |
Posizioni
Director/Board Member | 183 |
Corporate Officer/Principal | 93 |
Independent Dir/Board Member | 46 |
Chief Executive Officer | 46 |
Chairman | 38 |
Contatti più connessi
Insiders | |
---|---|
Michael Rice | 33 |
Nissim Darvish | 27 |
Todd Pope | 26 |
Rajiv Sarman Shukla | 23 |
Susan Windham-Bannister | 20 |
Gordon Binder | 20 |
Lorin Johnson | 19 |
Walter Wilkinson | 18 |
Kathleen Sebelius | 18 |
Ed Sitar | 16 |
Max Wallace | 16 |
Charles Myers | 16 |
Brady Dougan | 15 |
Mark Sirgo | 15 |
Sandeep Laumas | 14 |
- Borsa valori
- Insiders
- Michael Constantino
- Connessioni Società